Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008-Reference-Cited by-同舟云学术

Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008

Published:2013-01-10 Issue:8 Volume:53 Page:1714-1721
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

McQuilten Zoe K.,Polizzotto Mark N.,Wood Erica M.,Sundararajan Vijaya

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12054/fullpdf

Reference31 articles.

1. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs;Rollison;Blood,2008

2. Myelodysplastic syndromes: incidence and survival in the United States;Ma;Cancer,2007

3. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries;Cogle;Blood,2011

4. A keyword search strategy to identify missed cases of myelodysplastic syndromes in population-based cancer registries;Cogle;ASH Annu Meet Abstr,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alloimmunization in myelodysplastic syndrome is associated with higher healthcare costs, longer hospitalizations, and increased mortality;Transfusion;2024-08-07

2. Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China;Laboratory Medicine;2024-07-26

3. Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes;Transfusion;2024-01-12

4. Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review;Blood Reviews;2023-09

5. Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort study;Transfusion Clinique et Biologique;2023-08